[1]
Mahapol, P. 2023. THE PREVALENCE AND ASSOCIATED RISK FACTORS OF REBOUND HYPERTHYROIDISM IN GRAVES’ DISEASE AFTER ANTI-THYROID DRUG DOSE REDUCTION (PARAGON STUDY). Journal of the ASEAN Federation of Endocrine Societies. 38, S3 (Nov. 2023), 104.